IRIS
CASTELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.508
AS - Asia 1.749
SA - Sud America 1.500
EU - Europa 422
AF - Africa 87
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.270
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.388
BR - Brasile 1.333
SG - Singapore 850
CN - Cina 280
HK - Hong Kong 186
VN - Vietnam 164
IT - Italia 107
AR - Argentina 74
DE - Germania 65
MX - Messico 52
FI - Finlandia 48
GB - Regno Unito 36
TR - Turchia 34
RU - Federazione Russa 29
CA - Canada 26
IQ - Iraq 26
ZA - Sudafrica 26
EC - Ecuador 25
IN - India 24
BD - Bangladesh 23
CO - Colombia 22
ID - Indonesia 21
JP - Giappone 20
MA - Marocco 20
UA - Ucraina 20
UZ - Uzbekistan 20
SE - Svezia 18
FR - Francia 16
AT - Austria 13
ES - Italia 12
JO - Giordania 12
PY - Paraguay 12
VE - Venezuela 12
AZ - Azerbaigian 11
PL - Polonia 11
KE - Kenya 10
PK - Pakistan 10
CL - Cile 8
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
AE - Emirati Arabi Uniti 7
HN - Honduras 7
NP - Nepal 7
RS - Serbia 7
TN - Tunisia 7
IL - Israele 6
KR - Corea 6
KZ - Kazakistan 6
NL - Olanda 6
UY - Uruguay 6
CR - Costa Rica 5
JM - Giamaica 5
LB - Libano 5
PH - Filippine 5
AL - Albania 4
EG - Egitto 4
LT - Lituania 4
PE - Perù 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AU - Australia 3
BE - Belgio 3
BO - Bolivia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
GE - Georgia 3
KG - Kirghizistan 3
PA - Panama 3
SN - Senegal 3
BB - Barbados 2
BN - Brunei Darussalam 2
GT - Guatemala 2
HU - Ungheria 2
IE - Irlanda 2
KW - Kuwait 2
NI - Nicaragua 2
SV - El Salvador 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
IR - Iran 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NA - Namibia 1
NG - Nigeria 1
OM - Oman 1
Totale 6.264
Salva come PNG Salva come JPEG
Città #
Dallas 1.352
Singapore 435
Chandler 229
Hong Kong 186
Princeton 138
Beijing 95
Ashburn 85
São Paulo 83
New York 68
Ho Chi Minh City 63
Shanghai 46
Rio de Janeiro 43
Belo Horizonte 33
Helsinki 33
Brasília 30
Los Angeles 29
Curitiba 22
Hanoi 22
Tokyo 20
Milan 19
Munich 18
Santa Clara 16
Goiânia 15
Tashkent 15
Campinas 14
Porto Alegre 14
Ribeirão Preto 14
Baghdad 13
Guarulhos 13
Nuremberg 13
Falkenstein 12
Fortaleza 12
Johannesburg 12
Santo André 12
Stockholm 12
Amman 11
Columbus 11
Denver 11
Duque de Caxias 11
Orem 11
Poplar 11
Sassari 11
São José dos Campos 11
The Dalles 11
Warsaw 11
Atlanta 10
Baku 10
Frankfurt am Main 10
Montreal 10
Nairobi 10
Sorocaba 10
Brooklyn 9
Da Nang 9
Düsseldorf 9
Franca 9
Mexico City 9
Quito 9
Tianjin 9
Turku 9
Bogotá 8
Campo Grande 8
Cape Town 8
Chennai 8
Joinville 8
Petrópolis 8
Recife 8
Vienna 8
Asunción 7
Betim 7
Brno 7
Casablanca 7
Juiz de Fora 7
London 7
Maceió 7
Manaus 7
Olbia 7
Shenzhen 7
São Gonçalo 7
Ankara 6
Catanduva 6
Caxias do Sul 6
Conselheiro Lafaiete 6
Contagem 6
Cotia 6
Cuiabá 6
Guayaquil 6
Haiphong 6
Istanbul 6
Itapevi 6
Lappeenranta 6
Medellín 6
Montevideo 6
Moscow 6
Phoenix 6
Piracicaba 6
Praia Grande 6
Salvador 6
San Francisco 6
Seoul 6
São Bernardo do Campo 6
Totale 3.751
Salva come PNG Salva come JPEG
Nome #
Impact of recombinant erythropoietin on anemia, physical function, and cognitive assessment in hospitalized older adults 338
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect 204
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 152
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 145
ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms 126
Brachial Tunneled Peripherally Inserted Central Catheters and the Risk of Catheter Complications: A Systematic Review and Meta-Analysis 124
Aging of the Arterial System 113
Cancer and thromboembolism: from biology to clinics 112
Angioedema due to acquired C1-inhibitor deficiency : a bridging condition between autoimmunity and lymphoproliferation 111
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 104
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management 103
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study 100
Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients 93
Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function 93
Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis 92
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 92
Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection 91
Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release 90
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity 87
Current and Emerging Treatment Options for Patients with Relapsed Myeloma 86
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes 84
Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction 83
Choosing treatment options for patients with relapsed/refractory multiple myeloma 83
Acquired C1-inhibitor deficiency and lymphoproliferative disorders : a tight relationship 80
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 80
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA 78
Midline peripheral catheters inserted in the superficial femoral vein at mid-thigh: Wise choice in COVID-19 acute hypoxemic respiratory failure patients with helmet continuous positive airway pressure 78
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies : from pathophysiology to the clinic 76
Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatments 75
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 74
The impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients 74
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 73
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas 72
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women : effect of weight loss obtained by gastric banding 71
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study 70
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review 69
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia 69
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization 69
Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia 68
Management of anaemia in onco-haematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study 67
Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course 66
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia : case reports and literature review 66
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation 66
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy : clinical report of three patients 65
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects 65
Clinical Characteristics and treatment outcome of an 86-year old patient with acute myeloid leukemia with acute promyelocytic - like morphology and uncommon RARA fusion variant 64
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update 64
Interaction of C1 inhibitor with thrombin on the endothelial surface 63
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma 62
The heparins and cancer: review of clinical trials and biological properties 62
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia 60
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated With Thrombopoietin Receptors Agonists 60
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism 59
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor 59
Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study 58
Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I 57
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 57
Immunomodulatory drugs in multiple myeloma : from molecular mechanisms of action to clinical practice 56
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients 56
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update 55
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update 54
Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report 54
The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes 54
Thrombosis and hemostatic Abnormalities in haematological malignancies 52
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis 52
Thromboembolic complications in malignant haematological disorders 52
Ibrutinib related bleeding complications in elderly patients with B cell malignancies 50
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate 50
Rheumatoid factors : clinical applications 49
Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate 48
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 47
Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy 47
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy 47
null 45
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope 45
Intrathoracic masses due to extramedullary hematopoiesis 45
Integrated short peripheral intravenous cannulas and risk of catheter failure: A systematic review and meta-analysis 43
New antithrobotic agents 42
Personalized treatment strategies for elderly patients with myelodysplastic syndromes 42
Eltrombopag treatment for thrombocytopenia in myelodysplastic syndromes: differences between responding and non-responding patients—a pilot study 41
Eltrombopag reduces bleeding complications and the need of platelet transfusions in cirrhotic thrombocytopenic patients subjected to invasive procedures 41
Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents 41
Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality 37
Risk-tailored treatment of splenic marginal zone lymphoma 36
Lymphoproliferative disease and acquired C1 inhibitor deficiency 34
Laboratory and clinical risk assessment to treat myelodysplatic syndromes 32
Unreliable estimation of HbA due to the presence of Camperdown haemoglobin [beta 104 (G6) Arg --> Ser] 31
High Rate of hepatitis B viral breakthrought in elderly non Hodgkin lymphomas patients treated with Rituximab based chemotherapy 3
Totale 6.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022200 0 0 0 0 0 0 83 0 3 4 21 89
2022/2023515 69 0 2 85 50 77 0 85 96 8 25 18
2023/2024213 26 22 5 3 8 57 2 10 0 6 17 57
2024/20252.370 10 13 84 24 104 81 169 631 800 294 69 91
2025/20263.085 153 950 831 797 321 33 0 0 0 0 0 0
Totale 6.383